Yazar "Başaran, Ebru" için Farmasötik Teknoloji Anabilim Dalı listeleme
-
Chitosan nanoparticles for ocular delivery of cyclosporine A
Başaran, Ebru; Yenilmez, Evrim; Berkman, Murat Sami; Büyükköroğlu, Gülay; Yazan, Yasemin (Taylor & Francis LTD, 2014)In the present study, cyclosporine A (CsA) was successfully incorporated into cationic chitosan nanoparticles by spray-drying method aiming ocular application. Physicochemical characterisation of particles was performed ... -
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
Başaran, Ebru; Demirel, Müzeyyen; Sırmagül, Başar; Yazan, Yasemin (Taylor & Francis LTD, 2010)In the present study, Cyclosporine A (CsA) was successfully incorporated into cationic solid lipid nanoparticles (SLN) for ocular application. Physicochemical characterizations of SLNs were analysed in detail during the ... -
Ocular application of chitosan
Başaran, Ebru; Yazan, Yasemin (Taylor & Francis LTD, 2012)Introduction: A major problem in ocular therapeutics with classical formulations is the maintenance of an effective drug concentration at the site of action for a long period of time. Enhancement of ocular bioavailability ... -
Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation
Başaran, Ebru (Turkish Pharmacists Assoc, 2017)Objectives: Ocular drug delivery is a difficult challenge especially with topical intillation which results in rapid drainage and non-productive drug absorption. For the improvement of the pre-corneal retention time and ... -
Ornidazole Incorporated Chitosan Nanoparticles for Ocular Application
Başaran, Ebru; Şenel, Behiye; Kırımlıoğlu, Gülsel Yurtdaş; Güven, Umay Merve; Yazan, Yasemin (Colegio Farmaceuticos Provincia De Buenos Aires, 2015)Considering the low ocular bioavailability of conventional formulations used for ocular bacterial infection treatment, there is a need for developing efficient modern drug delivery systems. Main attempt in this study was ... -
Ornidazole incorporated chitosan nanoparticles for ocular application
Başaran, Ebru; Şenel, Behiye; Kırımlıoğlu, Gülsel Yurtdaş; Güven, Umay Merve; Yazan, Yasemin (Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2015)Considering the low ocular bioavailability of conventional formulations used for ocular bacterial infection treatment, there is a need for developing efficient modern drug delivery systems. Main attempt in this study was ... -
Polymeric Cyclosporine-A Nanoparticles for Ocular Application
Başaran, Ebru; Demirel, Müzeyyen; Sırmagül, Başar; Yazan, Yasemin (Amer Scientific Publishers, 2011)In the present study, cyclosporine A (CsA) was incorporated successfully into cationic Eudragit(R) RS 100 nanoparticles (EPNs) aiming ocular application. Physicochemical characterization of the EPNs prepared was performed ... -
Preparation and in vitro characterization of a fluconazole loaded chitosan particulate system
Kırımlıoğlu, Gülsel Yurtdaş; Yenilmez, Evrim; Başaran, Ebru; Yazan, Yasemin (İstanbul Medipol University, 2019)In the present study fluconazole (FZ) was successfully incorporated into cationic chitosan nanoparticles prepared by spray-drying method aiming dermal delivery. Particle size and zeta potential measurements, drug content, ... -
Preparation, Characterization and In Vitro Evaluation of Dirithromycin Loaded Eudragit (R) RS 100 Nanoparticles for Topical Application
Yenilmez, Evrim; Kırımlıoğlu, Gülsel Yurtdaş; Şenel, Behiye; Başaran, Ebru (Colegio Farmaceuticos Provincia De Buenos Aires, 2017)The purpose of the study was to formulate dirithromycin (DR) loaded Eudragit (R) RS 100 (ERS) nanoparticles for topical application and to analyze the physical and chemical characteristics and in vitro toxicity of the ... -
Studies on rosuvastatin calcium incorporated chitosan salt nanoparticles
Al-Heibshy, Fawaz N. S.; Başaran, Ebru; Demirel, Müzeyyen (Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2016)Cardiovascular diseases are the leading causes of death worldwide and rosuvastatin calcium (RCa) is one of the most effective drugs used for the prevention of coronary heart diseases. Considering low aqueous solubility ... -
Voriconazole Incorporated Polymeric Nanoparticles for Ocular Application
Başaran, Ebru; Gencer, Hülya Karaca; Yenilmez, Evrim; Güven, Umay M. (Colegio Farmaceuticos Provincia De Buenos Aires, 2017)Limitations of topical ocular application lead to unsufficient treatment in severe ocular disorders, therefore the researchers focused on novel drug delivery systems for the achievement of enhanced ocular bioavailability. ... -
Voriconazole incorporated polymeric nanoparticles for ocular application
Başaran, Ebru; Karaca Gencer, Hülya; Yenilmez, Evrim; Güven, Umay Merve (Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2017)Limitations of topical ocular application lead to unsufficient treatment in severe ocular disorders, therefore the researchers focused on novel drug delivery systems for the achievement of enhanced ocular bioavailability. ...